Clinical Trials Directory

Trials / Terminated

TerminatedNCT02428010

Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study

Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients With Severe, Symptomatic Mitral Regurgitation

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Medtronic Cardiovascular · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study to evaluate the safety and performance of the Twelve TMVR System

Detailed description

The study is a prospective, multi-center, non-randomized trial to evaluate the safety and performance of the Twelve TMVR System in very high risk patients with severe, symptomatic mitral regurgitation.

Conditions

Interventions

TypeNameDescription
DEVICETMVR ImplantImplantation of the Twelve TMVR System

Timeline

Start date
2014-09-01
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2015-04-28
Last updated
2021-05-04

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT02428010. Inclusion in this directory is not an endorsement.

Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study (NCT02428010) · Clinical Trials Directory